Txinno Bioscience at BIO-Europe 2026

Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website

Txinno Bioscience at BIO-Europe 2026 in Cologne: 1 session (1 talk).

OrganizationBIO-Europe 2026 Attendance
txinno.com
Biotech
Korean developer of small-molecule cancer drugs.
Talk
Mon Nov 9
14:45–15:00
Immuno-Oncology: Txinno Bioscience Inc.
Small molecule drugs and protein degraders for cancer, with Korean approval to start a mid-stage trial of the lead drug.

Explore the full BIO-Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Cologne. Leave your work email and we’ll be in touch.

Privacy

Download the full BIO-Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Txinno Bioscience

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by BIO-Europe or its organizers. Submit a correction